Efficacy and safety of PD‑1/PD‑L1 inhibitors combined with chemotherapy in patients with advanced gastric or gastro‑esophageal junction cancer: A systematic review and meta‑analysis

Although the efficacy and safety of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitor combined with chemotherapy vs. chemotherapy alone has been analyzed, there have been no in-depth studies on the outcomes of patients with PD-L1 positive advanced gastric or gastro-esop...

Descripción completa

Detalles Bibliográficos
Autor principal: Su, Shiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410198/
https://www.ncbi.nlm.nih.gov/pubmed/37564826
http://dx.doi.org/10.3892/ol.2023.13960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410198/
https://www.ncbi.nlm.nih.gov/pubmed/37564826
http://dx.doi.org/10.3892/ol.2023.13960

Ejemplares similares